Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis

Clinical Biochemistry

Volumn 41, Issue 16-17, 2008, Pages 1326-1329

  Djurić, Tamara ^a   Živković, Maja ^a   Radak, Djordje ^b   Jekić, Djole ^c   Radak, Sandra ^b   Stojković, Ljiljana ^a   Raičević, Ranko ^c   Stanković, Aleksandra ^a   Alavantić, Dragan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Dedinje Cardiovascular Institute   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

5A 6A; Carotid atherosclerosis; Gene polymorphism; Human; MMP 3

Indexed keywords

STROMELYSIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERBIA;

ADULT; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 55149085663     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.08.081     Document Type: Article

References (26)

1. Woessner Jr. J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5 (1991) 2145-2154
2. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17 (2001) 463-516
3. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
4. Kuzuya M., and Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J. Atheroscler. Thromb. 10 (2003) 275-282
5. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc. Res. 69 (2006) 636-645
6. Henney A.M., Wakeley P.R., Davies M.J., et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. 88 (1991) 8154-8158
7. Ye S., Erikson P., Hamsten A., Kurkinen M., Humpries S.E., and Henney A.M. Progression of coronary atherosclerosis is associated with common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 271 (1996) 13055-13060
8. Zhu C., Odeberg J., Hamsten A., and Eriksson P. Allele-specific MMP-3 transcription under in vivo conditions. Biochem. Biophys. Res. Commun. 348 (2006) 1150-1156
9. Ye S., Watts G.F., Mandalia S., Humphries, and Henney A.M. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Brit. Heart. J. 73 (1995) 209-215
10. Humphries S.E., Luong L.A., Talmud P.J., et al. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Atherosclerosis 139 (1998) 49-56
11. Hirashiki A., Yamada Y., Murase Y., et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J. Am. Coll. Cardiol. 42 (2003) 1429-1437
12. Beyzade S., Zhang S., Wong Y.K., Day I.N., Eriksson P., and Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J. Am. Coll. Cardiol. 41 (2003) 2130-2137
13. Schwarz A., Haberbosch W., Tillmanns H., and Gardemann A. The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease. Dis. Markers 18 (2002) 121-128
14. Ye S., Gale C.R., and Martyn C.N. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur. Heart J. 24 (2003) 1668-1671
15. Ghilardi G., Biondi M.L., DeMonti M., Turri O., Guagnellini E., and Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33 (2002) 2408-2412
16. Gnasso A., Motti C., Irace C., et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1600-1605
17. Rauramaa R., Väisänen S.B., Luong L.A., et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2657-2662
18. Rundek T., Elkind M.S., Pittman J., et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33 (2002) 1420-1423
19. Beilby J.P., Chapman C.M., Palmer L.J., McQuillan B.M., Thompson P.L., and Hung J. Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population. J. Hypertens. 23 (2005) 537-542
20. Wyman R.A., Fraizer M.C., Keevil J.G., et al. Ultrasound-detected carotid plaque as a screening tool for advanced subclinical atherosclerosis. Am. Heart J. 150 (2005) 1081-1085
21. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
22. Kunkel L.M., Smith K.D., Boyer S.H., et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc. Natl. Acad. Sci. USA. 74 (1977) 1245-1249
23. Djurić T., Zivković M., Stanković A., Mecanin S., and Alavantić D. Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population. J. Clin. Lab. Anal. 19 (2005) 241-246
24. Galis Z.S., Sukhova G.K., Lark M.W., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94 (1994) 2493-2503
25. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., and Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res. 92 (2003) 1254-1261
26. Abilleira S., Bevan S., and Markus H.S. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J. Med. Genet. 43 (2006) 897-901